Search PubMed⌕ Search

Biomedical subjects

H Mitchell

Publications and source records attributed to H Mitchell.

151 records · Page 9Linked to original sources

The use of parent report to assess the quality of care in primary care visits among children with asthma.

OBJECTIVE: To determine the accuracy of parent report and the accuracy of the medical record in documenting physician performance of elements of pediatric asthma care in the primary care setting. METHODS: A convenience sample of 79 English-speaking parents of 4--12-year old children with asthma presenting to medical center--affiliated inner-city primary care pediatric clinics in the Bronx, Dallas, and Chicago was enrolled, and the office visit was audiotaped. Parents were interviewed 1--16 days after the visit by telephone. OUTCOME MEASURES: Accuracy of parent report was the primary outcome. The "reference standard" was an independent evaluation of the audiotaped record of the primary care visit. The National Asthma Education and Prevention Program was used as a guide to select data elements to assess quality of pediatric asthma care during primary care visits. RESULTS: Sufficient documentation was significantly (P <.001) less likely to be present in the medical record than in the follow-up interview for each element of care. When these elements were combined into a cumulative score, 71% of parent interviews but only 37% of medical records scored > or = 5 (out of a possible 6), with 29% of medical records scoring < 3. Parents were able to accurately report (concordance of parent data with audiotape reference standard) whether or not the visit had included performance of 5 of the 6 elements of care. CONCLUSIONS: Our study suggests that parent telephone interview within 2 weeks after the visit is more accurate than the medical record for documentation of the quality of asthma care in pediatric primary care visits. The medical record was not sufficient to assess the quality of primary care related to asthma, primarily because of missing data. Therefore, our data suggest that assessing quality of care using the medical record will not only bias the findings in the direction of more deficient care but will also make improvement in care more difficult. Further validation of our strategy for using parent report to assess the quality of care in primary care visits will require its application in a variety of other primary care settings.

Asthma↗

Papanicolaou smears in Victoria: are the wrong women being screened?

While a mismatch is evident in the age distribution of women who are smear-tested by the Victorian Cytology (Gynaecological) Service (VC(G)S) and the women who are developing and dying of invasive cancer of the cervix, evidence is presented that the screened population have significant morbidity from precursor lesions. Women whose cervical cytological examination is undertaken by the VC(G)S have higher detection rates for carcinoma-in-situ than does the general population; a more than three-fold excess over the SA Cancer Registry rates is evident. During 1984 one in 148 of the women who were screened by the VC(G)S had histologically-proved dysplasia or carcinoma-in-situ in contrast with one in 5606 Australian women who were diagnosed as having invasive cancer of the cervix. These results indicate that the women who are currently screened should not be considered an intrinsically low-risk group for cervical malignancy.

Adult↗

Influence of endocervical status on the cytologic prediction of cervical intraepithelial neoplasia.

A case-control analysis of the endocervical status of smears that preceded a histologic diagnosis of cervical intraepithelial neoplasia (CIN) showed that smears which correctly predicted CIN were significantly more likely to include metaplastic cells than were smears reported to be negative. There was no significant difference between the smears with respect to the presence of columnar cells. A high level of agreement was apparent between scientists in determining both columnar and metaplastic cell status. A discussion of the definition, role and potential impact of endocervical status in the prevention of cervical cancer is presented.

Adult↗

Statistical measurements of accuracy in cervical cytology.

Statistical measures that can be used to monitor the level of accuracy of cervical cytologic screening are examined: sensitivity, the false-negative rate, the interval cancer rate among women with negative reports and the predictive value of a positive test. Sensitivity and the false-negative rate are subject to biases and problems of determination that may make them less useful as measures of accuracy. The interval cancer rate and the positive predictive value may be better methods of assessing the frequency of serious abnormalities following negative cytologic reports and the accuracy of cytologic reports of serious abnormalities, respectively. It is important to recognize that no single measure of accuracy can adequately define a laboratory's performance. The use of statistical analyses can be invaluable in placing in context the criticisms of cervical cytology as an appropriate screening test for the prevention of cervical cancer; statistical analysis should be used as one component of quality control.

Cervix Uteri↗

Quality control measures for cervical cytology laboratories.

The results of three quality control measures for evaluating a cytopathology laboratory's performance in the diagnosis of cervical abnormalities are presented. The sensitivities of cervical cytology were estimated to be 95.5% or 93.1% (using two different methods of analysis) for the detection of histologically diagnosed invasive squamous cell carcinoma of the cervix and 60% for the detection of adenocarcinoma and adenosquamous carcinoma of the cervix in 1983. The positive predictive values for a histologic diagnosis of neoplasia after cytologic reports of CIN III and invasive carcinoma were 92.5% and 99%, respectively. Repeatability of a negative cytologic result exceeded 98%. These results indicate that accurate cervical cytologic reporting can be achieved. Regular monitoring of the type described, which is both practical and reasonably comprehensive, is recommended for all laboratories.

Adenocarcinoma↗

Consistency of reporting endocervical cells. An intralaboratory and interlaboratory assessment.

A study of the intralaboratory and interlaboratory consistency of reporting endocervical cells on cytologic smears is presented. Two sets of 40 slides were compiled from previously reported material. Twenty-two laboratories each reported one set of the slides according to a single coding schedule. The intralaboratory agreement on the endocervical cell code was 80%. Considerable variation was evident between laboratories. While only 14% of the 80 slides received a unanimous endocervical code across the 11 reviewing laboratories, 73 of the 80 slides had agreement by at least 7 of the 11 reviewing laboratories. If the coding option "minor reactive and inflammatory changes in endocervical cells" was amalgamated with the coding option "normal endocervical cells present," a substantial improvement in the level of agreement resulted. The probability of agreement between laboratories did not vary according to whether the subsequent histology/cytology was reported as negative or as a low grade abnormality.

Adenocarcinoma↗

Multicentre clinical evaluation of the COBAS CORE CEA, CA 125 II and PSA tumor marker assays.

The aim of our study was to evaluate the clinical usefulness of the tumor markers CEA, CA 125 and PSA using the COBAS CORE system from Roche Diagnostic Systems. Our results demonstrate that determination of these markers on the COBAS CORE immunoassay analyser provides the performance required for routine use in clinical practice. The results obtained in this clinical trial validate the correlation with disease extension, a characteristic that defines and determines the clinical utility of the tumor markers. We also conclude that learning to operate the COBAS CORE system is simple, as is management of the system through the user-friendly software.

Adolescent↗